Predict your next investment

HEALTHCARE | Drug Development
genefrontier.com

See what CB Insights has to offer

Stage

Corporate Minority | Alive

About GeneFrontier Corporation

Provider of genomic drug discovery research services. The company offers a biotechnology tool, diagnostics, and therapeutics exploring the potential of protein-based biologics. The company also provides a customised human monoclonal antibody service using recombinant antibody technology for providing monoclonal antibodies. Based in Kashiwa, Chiba prefecture.

GeneFrontier Corporation Headquarter Location

5-4-19

Kashiwa, 277-0882,

Japan

04-7137-6301

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

GeneFrontier Corporation Patents

GeneFrontier Corporation has filed 14 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • EC 3.4.24
  • Human proteins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/20/2020

12/15/2020

Clusters of differentiation, Immunology, Immune system, Monoclonal antibodies, Proteins

Grant

Application Date

2/20/2020

Grant Date

12/15/2020

Title

Related Topics

Clusters of differentiation, Immunology, Immune system, Monoclonal antibodies, Proteins

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.